Sildenafil
FDA Approved
Contents
Description
Sildenafil is a phosphodiesterase-5 inhibitor used to treat pulmonary arterial hypertension. It works by relaxing blood vessels in the lungs to allow blood to flow more easily. While primarily indicated for pulmonary hypertension, it has been used off-label in managing vascular complications in various congenital syndromes.
Indications & Therapeutic Use
Pulmonary arterial hypertension, vascular complications in congenital anomalies
Global Availability (7 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Sildenafil — GNH India
753 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Abeced
EU
Abedel
EU
Actigra
EU
Actigra Forte
EU
Almus Erectile Dysfunction Relief
EU
Amfidor
EU
Aronix
EU
Asda
EU
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Sildenafil
| Generic Name | Sildenafil |
| Brands | 1 brand available |
| Active Ingredient | Sildenafil citrate |
| Drug Class | Pulmonary arterial hypertension |
| Manufacturer | Pfizer |
| Dosage Forms | Oral tablet 20mg, IV injection 0.8mg/mL |
| Medical Code | C02KX01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT00910221 |
| Countries | 7 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations8 Validated Nodes